5:09 PM
 | 
Jan 23, 2012
 |  BC Extra  |  Financial News

Ophthalmic company Eyevensys debuts

Ophthalmic company Eyevensys S.A.S. (Paris, France) raised EUR 950,000 ($1.2 million) from InnoBio Fund and Inserm Transfer Initiative. InnoBio...

Read the full 75 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >